Nicotinic Acetylcholine Receptor beta (CHRNB1) (Middle Region) Peptid
Kurzübersicht für Nicotinic Acetylcholine Receptor beta (CHRNB1) (Middle Region) Peptid (ABIN8106491)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- CHRNB1 Peptide - middle region
-
Sequenz
- GLILAQLISL NEKDEEMSTK VYLDLEWTDY RLSWDPAEHD GIDSLRITAE
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti- CHRNB1 Antibody (ARP80493_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CHRNB1 (Nicotinic Acetylcholine Receptor beta (CHRNB1))
-
Hintergrund
-
Background Information: The muscle acetylcholine receptor is composed of five subunits: two alpha subunits and one beta, one gamma, and one delta subunit. This gene encodes the beta subunit of the acetylcholine receptor. The acetylcholine receptor changes conformation upon acetylcholine binding leading to the opening of an ion-conducting channel across the plasma membrane. Mutations in this gene are associated with slow-channel congenital myasthenic syndrome.
Alternative Symbols: ACHRB, CHRNB, CMS1D, CMS2A, CMS2C, SCCMS
-
Molekulargewicht
- 55 kDa
-
Gen-ID
- 1140
-
NCBI Accession
- NP_000738
-
UniProt
- P11230
Target
-